Related Experiment Video
Updated: Jul 13, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Beta-arrestin-biased ligands at seven-transmembrane receptors
Jonathan D Violin1, Robert J Lefkowitz
1Department of Medicine, Howard Hughes Medical Institute, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Seven-transmembrane receptors (7TMRs), the most common molecular targets of modern drug therapy, are critically regulated by beta-arrestins, which both inhibit classic G-protein signaling and initiate distinct beta-arrestin signaling. The interplay of G-protein and beta-arrestin signals largely determines the cellular consequences of 7TMR-targeted drugs. Until recently, a drug's efficacy for beta-arrestin recruitment was believed to be proportional to its efficacy for G-protein activities. This paradigm restricts 7TMR drug effects to a linear spectrum of responses, ranging from inhibition of all responses to stimulation of all responses. However, it is now clear that 'biased ligands' can selectively activate G-protein or beta-arrestin functions and thus elicit novel biological effects from even well-studied 7TMRs. Here, we discuss the current state of beta-arrestin-biased ligand research and the prospects for beta-arrestin bias as a therapeutic target. Consideration of ligand bias might have profound influences on the way scientists approach 7TMR-targeted drug discovery.
Insights
Biased ligands offer new therapeutic strategies by selectively targeting seven-transmembrane receptors (7TMRs) and their beta-arrestin pathways. This approach moves beyond traditional drug responses, enabling novel biological effects and drug discovery.
Area of Science:
- Pharmacology
- Molecular Biology
- Cellular Signaling
Background:
- Seven-transmembrane receptors (7TMRs) are key drug targets, modulated by beta-arrestins that control G-protein and beta-arrestin signaling pathways.
- The balance between G-protein and beta-arrestin signals dictates cellular responses to 7TMR-targeted drugs.
- Previously, drug efficacy for beta-arrestin recruitment was thought to correlate directly with G-protein activity, limiting drug effects to a linear spectrum.
Purpose of the Study:
- To review the current landscape of beta-arrestin-biased ligand research.
- To explore the therapeutic potential of beta-arrestin bias in drug discovery.
- To highlight the impact of biased ligand concepts on 7TMR drug development.
Main Methods:
- Literature review and synthesis of current research on beta-arrestin-biased ligands.
- Analysis of the interplay between G-protein and beta-arrestin signaling.
- Discussion of the implications for 7TMR drug discovery paradigms.
Main Results:
- Biased ligands can selectively activate G-protein or beta-arrestin functions.
- This selectivity allows for novel biological effects from established 7TMRs.
- The traditional linear model of drug response is being challenged.
Conclusions:
- Beta-arrestin bias represents a significant area for therapeutic target exploration.
- Understanding ligand bias is crucial for advancing 7TMR drug discovery.
- This paradigm shift may redefine approaches to developing drugs targeting 7TMRs.
Related Concept Videos
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
G-protein Coupled Receptors
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...

